CIBMTR Reporting Implementation Guide
0.1.6 - Trial Use 1
CIBMTR Reporting Implementation Guide
0.1.6 - Trial Use 1
This page is part of the CIBMTR Reporting Implementation Guide (v0.1.6: Release Draft) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions 
| Official URL: http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/snomed-myelodysplastic-diseases-vs | Version: 0.1.6 | |||
| Active as of 2023-05-05 | Computable Name: SNOMEDMyelodysplasticDiseasesVS | |||
The myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell diseases characterized by cytopenia(s), dysplasia (abnormal growth or development leading to an alteration in size, shape, and organization of the cell) in one or more of the major myeloid cell lines (WBC, RBC, and/or platelets), ineffective hematopoiesis, and an increased risk of developing acute myelogenous leukemia (AML). MDS occurs primarily in older adults, with a median age of 70 years. The majority of recipients present with symptoms related to cytopenias. Most recipients present with anemia requiring RBC transfusions.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://snomed.info/sct where concept is-a 109995007 (Myelodysplastic syndrome (clinical))
This value set contains 17 concepts
Expansion based on SNOMED CT International edition 31-Jan 2023
| Code | System | Display |
| 109995007 | http://snomed.info/sct | Myelodysplastic syndrome (clinical) |
| 109996008 | http://snomed.info/sct | Refractory anaemia (clinical) |
| 109998009 | http://snomed.info/sct | Refractory anemia with sideroblasts |
| 110000005 | http://snomed.info/sct | Refractory anaemia with excess blasts in transformation (clinical) |
| 277597005 | http://snomed.info/sct | Myelodysplastic syndrome with isolated del(5q) (disorder) |
| 307340003 | http://snomed.info/sct | Monosomy 7 syndrome |
| 398623004 | http://snomed.info/sct | Refractory anaemia with excess blasts |
| 415283002 | http://snomed.info/sct | Refractory anemia with excess blasts-1 |
| 415284008 | http://snomed.info/sct | Refractory anemia with excess blasts-2 |
| 415285009 | http://snomed.info/sct | Refractory cytopenia with multilineage dysplasia |
| 415286005 | http://snomed.info/sct | Refractory cytopenia with multilineage dysplasia and ringed sideroblasts |
| 702476004 | http://snomed.info/sct | Therapy-related myelodysplastic syndrome (disorder) |
| 705061009 | http://snomed.info/sct | Childhood myelodysplastic syndrome (disorder) |
| 721303001 | http://snomed.info/sct | Refractory neutropenia (disorder) |
| 721304007 | http://snomed.info/sct | Refractory thrombocytopenia (disorder) |
| 1153345005 | http://snomed.info/sct | Refractory cytopaenia with unilineage dysplasia |
| 1177173001 | http://snomed.info/sct | Congenital progressive bone marrow failure, B-cell immunodeficiency, skeletal dysplasia syndrome (disorder) |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |